Yuri Matteo Falzone

Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

L. Pozzi, L. Leocani, A. Chiò, 2019, The Lancet Neurology.